RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma (Q38920937)

7 September 2017

title

RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma (English)

1 reference

esophageal squamous cell carcinoma

7 September 2017

main subject

1 reference

Wei Guo

1

1 reference

7 September 2017

Cong Wang

2

1 reference

7 September 2017

Yanli Guo

3

1 reference

7 September 2017

Supeng Shen

4

1 reference

7 September 2017

Xin Guo

5

1 reference

7 September 2017

Gang Kuang

6

1 reference

7 September 2017

Zhiming Dong

7

1 reference

7 September 2017

publication date

13 January 2015

1 reference

Clinical & Experimental Metastasis

7 September 2017

published in

1 reference

7 September 2017

volume

32

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

83-98

1 reference

Esophageal cancer: an update

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

The RASSF1A tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Identification of Nore1 as a potential Ras effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Epigenetic inactivation of the NORE1gene correlates with malignant progression of colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

NORE1A tumor suppressor candidate modulates p21CIP1 via p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

MethPrimer: designing primers for methylation PCRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

DNA methylation markers and early recurrence in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-015-9693-6

Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.

21 January 2018

1 reference

12 December 2020

Chromatin immunoprecipitation assay

1 reference

12 December 2020

Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China

1 reference

12 December 2020

Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis

1 reference

12 December 2020

The RASSF proteins in cancer; from epigenetic silencing to functional characterization

1 reference

12 December 2020

NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers

1 reference

12 December 2020

Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma

1 reference

12 December 2020

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma

1 reference

12 December 2020

SnapShot: Ras Signaling

1 reference

12 December 2020

10.1007/S10585-015-9693-6

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1016053511

0 references

1 reference